Safety and Tolerability of NRL-1, an Intranasal Formulation of Diazepam, in Relationship to Usage Frequency in Subjects With Epilepsy: Interim Results From a Phase 3, Open-label, Repeat Dose Study (1992)
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.94.15_supplement.1992